Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MVR-C5252 |
| Trade Name | |
| Synonyms | MVR C5252|MVRC5252|C5252|C-5252|C 5252 |
| Drug Descriptions |
MVR-C5252 is an oncolytic herpes simplex virus type 1 modified to express IL-12 and an antibody targeting PDCD1 (PD-1), which potentially activates an anti-tumor immune response (Cancer Res (2025) 85 (8_Supplement_2): CT056, NCI Drug Dictionary). |
| DrugClasses | PD-L1/PD-1 antibody 133 |
| CAS Registry Number | NA |
| NCIT ID | C184943 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| MVR-C5252 | MVR-C5252 | 0 | 2 |